In the final draft of the fiscal cliff law, Democratic and Republican senators snuck in a provision to give Amgen $500 million. The provision gives Amgen a further two-year extension to sell Sensipar, a drug for kidney dialysis patients, free from government Medicare price restrictions. Amgen has already received one extension. The senators received huge campaign contributions from Amgen. See the story at http://nyti.ms/VCCBmh. This may seem a drop in the bucket. But none of our money should be spent without a good reason. Otherwise, the politicians are simply laundering your money through Amgen and other corporations for their own campaigns.



